[Sensitivity of Yersinia pseudotuberculosis to antibiotics in vitro].
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D002701:Chloramphenicol / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009355:Neomycin / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010325:Pasteurella / Q000187:drug effects*; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D009675:Novobiocin; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D009355:Neomycin; D013307:Streptomycin
Sensibilität von Yersinia pseudotuberculosis gegen Antibiotika in vitro.